Medicus Pharma (NASDAQ:MDCX – Get Free Report) is anticipated to release its earnings data before the market opens on Friday, February 28th. Analysts expect Medicus Pharma to post earnings of ($0.32) per share for the quarter.
Medicus Pharma Stock Performance
NASDAQ:MDCX opened at $4.03 on Thursday. Medicus Pharma has a 52 week low of $1.80 and a 52 week high of $6.00. The stock has a 50 day moving average price of $2.95.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on MDCX shares. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a report on Monday, December 23rd. Maxim Group started coverage on Medicus Pharma in a report on Tuesday, December 17th. They set a “buy” rating and a $10.00 price target on the stock.
About Medicus Pharma
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
See Also
- Five stocks we like better than Medicus Pharma
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Buffett’s on the Sidelines – Should You Follow?
- Best Stocks Under $5.00
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What is Forex and How Does it Work?
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
